Alembic Pharmaceuticals Limited — Others, 24-01-2025: Copy of Newspaper Publication

Alembic Pharmaceuticals has announced a board meeting to discuss claims for shares from the company's Unclaimed Suspense Account, as detailed in a recent newspaper advertisement. The notice allows legal heirs, such as Kumudchandra Bhikhabhai Jain's heir, Vidit Jignesh Shah, to claim 150 shares. Interested parties must submit their claims with supporting documents within 15 days of the notice publication. Failure to do so will result in the transfer of shares to the claimant's demat account without further notice. This move underscores the company's commitment to shareholder engagement and may enhance investor sentiment by potentially resolving outstanding claims.